YPR011C Antibody

What is YPR011C and why is it significant for research?

YPR011C is a mitochondrial carrier protein in Saccharomyces cerevisiae that plays a crucial role in metabolite transport across the inner mitochondrial membrane. It is particularly significant for research because it transports adenosine 5′-phosphosulfate (APS) and 3′-phospho-adenosine 5′-phosphosulfate (PAPS), key intermediates in the sulfur assimilation pathway .

The protein has been linked to thermotolerance in yeast cells, with YPR011cΔ mutants showing reduced thermotolerance compared to wild-type cells when exposed to elevated temperatures (45°C) . Additionally, YPR011C is inserted into the inner mitochondrial membrane (IMM) by the TIM22 complex with the contribution of small Tim proteins, making it part of an important mitochondrial protein import pathway . Understanding this protein contributes to our knowledge of mitochondrial transport systems, sulfur metabolism, and cellular stress responses.

How does YPR011C function in cellular metabolism?

YPR011C functions as a transporter in the inner mitochondrial membrane that mediates the exchange of metabolites between the mitochondrial matrix and the cytosol. Specifically, it transports APS and PAPS, which are crucial intermediates in the sulfur assimilation pathway .

The protein exhibits a substrate specificity that affects cellular metabolism in several ways:

• It facilitates the transport of sulfur-containing compounds needed for the synthesis of methionine, cysteine, and glutathione.

• It contributes to thermotolerance, as demonstrated by reduced survival of YPR011cΔ mutants at elevated temperatures.

• It influences cellular levels of methionine and glutathione, particularly under stress conditions .

Kinetic studies with recombinant YPR011Cp have shown that the protein can be inhibited by externally added APS, PAPS, sulfate, and phosphate in a concentration-dependent manner, with APS and PAPS showing much higher inhibitory potency at lower concentrations than sulfate and phosphate .

What is the subcellular localization of YPR011C?

YPR011C is localized in the inner mitochondrial membrane (IMM) of yeast cells. This localization has been confirmed through multiple experimental approaches:

• Import studies using [35S]-labeled YPR011C showed reduced import in tim22-14 and tim10-2 mutant mitochondria, confirming that YPR011C is inserted into the IMM by the TIM22 complex with the contribution of small Tim proteins .

• Functional studies demonstrated that YPR011C operates as a transport protein in the mitochondrial membrane, mediating the exchange of metabolites between the mitochondrial matrix and the cytosol .

• Localization studies indicate that disruption of YPR011C affects mitochondrial functions, particularly those related to sulfur metabolism and thermotolerance, further supporting its mitochondrial localization .

The mitochondrial localization of YPR011C is essential for its physiological role in the transport of sulfur metabolism intermediates and its contribution to cellular thermotolerance.

What expression systems are most effective for producing recombinant YPR011C for antibody generation?

For producing recombinant YPR011C for antibody generation, Escherichia coli expression systems have proven effective, though with specific considerations:

E. coli M15 (pREP4) has been successfully used to express the YPR011C gene. The protein accumulates as inclusion bodies, which can be purified by centrifugation and washing . This approach yields protein with an apparent molecular mass of 42.3 kDa, which can be confirmed using MALDI-TOF mass spectrometry for identity verification .

When working with E. coli expression systems for YPR011C:

• Consider using a His-tag or similar affinity tag to facilitate purification.

• Be prepared for inclusion body formation, which may require denaturation and refolding protocols.

• Implement rigorous quality control to ensure proper folding and function of the purified protein.

• Validate protein identity through mass spectrometry or N-terminal sequencing.

For functional studies or generating antibodies against properly folded epitopes, reconstitution of the purified protein into liposomes might be necessary, as has been done for transport studies . This approach allows for the assessment of function while providing material suitable for immunization.

What are the optimal antigenic regions of YPR011C for targeting with antibodies?

The optimal antigenic regions of YPR011C for antibody targeting should be selected based on protein structure, functional domains, and accessibility. Although specific epitope mapping data for YPR011C is limited in the provided search results, a rational approach can be formulated based on mitochondrial carrier protein characteristics and the YPR011C functional data available:

• Avoid transmembrane regions: Since YPR011C is a mitochondrial carrier protein, it contains multiple transmembrane domains that are embedded in the lipid bilayer and less accessible for antibody binding.

• Target hydrophilic loops: Focus on hydrophilic loop regions that connect transmembrane segments, particularly those facing the intermembrane space or matrix, as these are more likely to be accessible.

• Consider functional domains: The regions involved in substrate binding (APS/PAPS) might be highly conserved and thus good targets for specific antibody development .

• N- or C-terminal regions: Terminal regions of mitochondrial carrier proteins often extend into aqueous environments and make good antibody targets if they're sufficiently unique to YPR011C.

Drawing from epitope mapping approaches used for other proteins like YB-1, researchers should consider developing antibodies against multiple epitopes distributed across different protein regions to increase the chances of obtaining functional antibodies . Computational tools for epitope prediction coupled with structural homology modeling of YPR011C can provide additional guidance for selecting optimal antigenic regions.

How can I validate the specificity of a YPR011C antibody?

Validating the specificity of a YPR011C antibody requires a multi-faceted approach to ensure reliable results in subsequent experiments:

• Western blot analysis with recombinant protein: Use purified recombinant YPR011C protein as a positive control to confirm antibody binding to the target at the expected molecular weight (approximately 42.3 kDa) .

• Knockout/knockdown controls: Compare antibody signal between wild-type and YPR011CΔ yeast strains. A specific antibody should show signal in wild-type samples but not in knockout samples .

• Cross-reactivity testing: Test the antibody against related mitochondrial carrier proteins to ensure it doesn't cross-react with similar proteins, especially those in the same family that cluster together phylogenetically .

• Immunoprecipitation followed by mass spectrometry: Immunoprecipitate proteins from yeast cell lysates using the YPR011C antibody, then identify the captured proteins by mass spectrometry to confirm specificity.

• Immunofluorescence with colocalization: Perform immunofluorescence staining and compare localization with known mitochondrial markers to confirm the expected subcellular localization pattern .

• Pre-absorption controls: Pre-incubate the antibody with purified YPR011C protein before immunostaining or Western blotting. This should abolish specific signals if the antibody is truly specific.

• Multiple antibody validation: If possible, validate results using antibodies raised against different epitopes of YPR011C to increase confidence in specificity.

For detailed methodological considerations, follow approaches similar to those used in antibody validation studies, adapting dilutions for primary and secondary antibodies as described in standard protocols (similar to those mentioned in Table 2.19 and 2.20 from search result ).

How can YPR011C antibodies be used to study protein-protein interactions in mitochondrial import pathways?

YPR011C antibodies can be powerful tools for investigating protein-protein interactions in mitochondrial import pathways, particularly those involving the TIM22 complex and small Tim proteins that facilitate YPR011C insertion into the inner mitochondrial membrane :

• Co-immunoprecipitation (Co-IP): Use YPR011C antibodies to pull down YPR011C and its interacting partners from solubilized mitochondrial membranes. Mass spectrometry analysis of co-precipitated proteins can identify novel interaction partners. This approach could reveal how YPR011C interacts with components of the TIM22 complex and small Tim proteins during its import and insertion process .

• Proximity-dependent biotin identification (BioID): Fuse YPR011C with a biotin ligase, express in yeast, and use YPR011C antibodies to confirm expression and localization. The biotin ligase will biotinylate proximal proteins, which can be purified and identified to map the YPR011C interaction network.

• Immunofluorescence microscopy with co-localization: Use YPR011C antibodies in combination with antibodies against known components of mitochondrial import machinery (TIM22, TIM10) to visualize their spatial relationships within mitochondria under various conditions .

• Blue native PAGE followed by immunoblotting: Employ YPR011C antibodies to detect the protein in native protein complexes separated by blue native PAGE, helping to identify stable complexes involving YPR011C and import machinery components.

• Chemical cross-linking combined with immunoprecipitation: Cross-link mitochondrial proteins, immunoprecipitate with YPR011C antibodies, and identify cross-linked partners by mass spectrometry to capture transient interactions during the import process.

When designing these experiments, consider the import defects observed in tim22-14 and tim10-2 mutant mitochondria as experimental controls, since these mutations reduce YPR011C import .

What are the best protocols for using YPR011C antibodies in immunohistochemistry or immunofluorescence studies?

For optimal results when using YPR011C antibodies in immunohistochemistry (IHC) or immunofluorescence (IF) studies of yeast cells, follow these methodological recommendations:

• Sample preparation:

  • For yeast cells: Fix with 4% paraformaldehyde for 30 minutes, then create spheroplasts using zymolyase treatment to allow antibody penetration through the cell wall.

  • For isolated mitochondria: Adhere to poly-L-lysine coated slides and fix with cold methanol followed by acetone.

• Permeabilization:

  • Use 0.1% Triton X-100 in PBS for 15 minutes to ensure antibody access to mitochondrial membranes while preserving structure.

• Blocking:

  • Block with 5% BSA or 5% normal serum (from the species in which the secondary antibody was raised) in PBS with 0.1% Tween-20 for 1 hour at room temperature.

• Primary antibody incubation:

  • Dilute YPR011C antibody appropriately (starting with 1:100-1:500 range for testing) in blocking buffer.

  • Incubate overnight at 4°C in a humidified chamber.

  • Include a co-staining with established mitochondrial markers (e.g., Tom20, Cox4) for co-localization studies .

• Secondary antibody incubation:

  • Use fluorophore-conjugated secondary antibodies specific to the host species of the YPR011C antibody.

  • Incubate for 1-2 hours at room temperature in the dark.

  • For mitochondrial co-localization, use secondaries with distinct fluorescence spectra.

• Counterstaining and mounting:

  • Counterstain nuclei with DAPI (1 μg/ml) for 5-10 minutes.

  • Mount with an anti-fade mounting medium to preserve fluorescence.

• Controls:

  • Include YPR011CΔ cells as negative controls .

  • Use pre-immune serum controls to assess background.

  • Include peptide competition controls where the antibody is pre-incubated with excess antigen.

• Visualization:

  • Use confocal microscopy for co-localization studies to accurately assess YPR011C localization in mitochondria.

  • Collect Z-stack images to fully capture the three-dimensional distribution of the protein.

Optimize antibody dilutions and incubation times empirically, as these can vary based on the specific antibody preparation and sample type.

How can I use YPR011C antibodies to study changes in protein expression under thermal stress conditions?

YPR011C antibodies can be effectively used to investigate changes in protein expression under thermal stress conditions, particularly given the protein's established role in yeast thermotolerance :

• Experimental design for thermal stress studies:

  • Grow yeast cultures (wild-type and YPR011CΔ strains) at normal temperature (30°C) until mid-log phase.

  • Subject cultures to thermal shift (e.g., from 30°C to 45°C) for various time periods (15 min, 30 min, 1 h, 2 h).

  • Collect cells and prepare protein extracts for analysis .

• Western blot analysis:

  • Separate proteins using SDS-PAGE (12% gels are suitable for detecting YPR011C at approximately 42.3 kDa).

  • Transfer to nitrocellulose or PVDF membranes.

  • Block membranes with 5% non-fat milk in TBS-t.

  • Incubate with optimized dilution of YPR011C antibody (as determined during validation).

  • Use appropriate HRP-conjugated secondary antibody and detect using enhanced chemiluminescence .

  • Quantify YPR011C band intensity relative to a loading control (e.g., actin, PGK1) using densitometry.

• Time-course analysis:

  • Monitor YPR011C expression at different time points during thermal stress to assess temporal changes.

  • Compare with expression patterns of known heat shock proteins (e.g., Hsp70) as positive controls for stress response .

• Subcellular fractionation:

  • Isolate mitochondrial fractions from cells before and after thermal stress.

  • Use YPR011C antibodies to determine if thermal stress affects mitochondrial localization or abundance of the protein.

• Correlation with physiological parameters:

  • Parallel analyses should assess cell viability, methionine levels, and glutathione content, which are known to be affected in YPR011CΔ mutants under thermal stress .

  • Plot YPR011C protein levels against these parameters to establish correlations.

• Two-dimensional gel electrophoresis:

  • Use 2D-PAGE followed by western blotting with YPR011C antibodies to detect post-translational modifications that may occur during thermal stress .

  • Follow IEF buffer and IPG strip equilibration protocols as described in Tables 2.21 and 2.22 .

• Comparative analysis:

  • Compare YPR011C expression patterns with data from qPCR and microarray analyses to correlate protein levels with transcriptional changes .

This methodical approach will provide insights into how YPR011C expression and potential post-translational modifications respond to thermal stress, furthering our understanding of its role in thermotolerance.

What are common challenges when working with YPR011C antibodies and how can they be overcome?

Working with antibodies against mitochondrial membrane proteins like YPR011C presents several challenges. Here are common issues and methodological solutions:

• Limited antibody accessibility to the target protein:

  • Challenge: YPR011C is embedded in the inner mitochondrial membrane, making epitopes less accessible.

  • Solution: For fixed samples, use stronger permeabilization methods (0.2-0.5% Triton X-100 or digitonin). For mitochondrial isolation, optimize solubilization conditions using mild detergents like DDM (n-dodecyl β-D-maltoside) or CHAPS at various concentrations to maintain protein structure while improving accessibility.

• Cross-reactivity with related mitochondrial carriers:

  • Challenge: YPR011C belongs to a family of mitochondrial carriers with similar sequences.

  • Solution: Pre-absorb antibodies with recombinant proteins from closely related family members. Alternatively, develop antibodies against unique peptide sequences specific to YPR011C. Always validate specificity using YPR011CΔ controls .

• Low signal-to-noise ratio:

  • Challenge: Mitochondrial autofluorescence or non-specific binding may obscure specific signals.

  • Solution: Increase blocking time (overnight at 4°C) with 5% BSA or normal serum. Test different blocking agents (milk, casein, commercial blockers). Use longer washing steps and increase the number of washes. Consider signal amplification methods like tyramide signal amplification for immunofluorescence.

• Variability in mitochondrial protein extraction efficiency:

  • Challenge: Inconsistent extraction of membrane-bound proteins between samples.

  • Solution: Standardize extraction protocols using specialized mitochondrial isolation kits. Consider using stronger solubilization methods like SDS for western blotting applications. Include internal controls like porin or other stable mitochondrial proteins.

• Epitope masking during fixation:

  • Challenge: Common fixatives may mask epitopes recognized by the antibody.

  • Solution: Test multiple fixation methods (paraformaldehyde, methanol, acetone) and compare results. Implement antigen retrieval methods before immunostaining. For some applications, consider using live-cell immunofluorescence with non-permeabilizing conditions for surface-exposed epitopes.

• Post-translational modifications affecting antibody recognition:

  • Challenge: Stress conditions may induce post-translational modifications that alter epitope recognition.

  • Solution: Develop multiple antibodies targeting different regions of YPR011C. Use 2D-PAGE to separate proteins based on both MW and pI before western blotting to detect modified forms .

• Quantification challenges:

  • Challenge: Accurate quantification of YPR011C expression levels across conditions.

  • Solution: Use fluorescence-based western blotting for wider dynamic range. Implement internal loading controls from the same subcellular compartment (other mitochondrial proteins). Consider absolute quantification using recombinant protein standards.

What are the best methods for quantifying YPR011C expression levels using antibody-based techniques?

For accurate quantification of YPR011C expression levels using antibody-based techniques, researchers should employ these methodological approaches:

• Quantitative Western Blotting:

  • Fluorescence-based detection: Use infrared fluorescent secondary antibodies (e.g., IRDye from LI-COR) for wider dynamic range and more accurate quantification compared to chemiluminescence.

  • Standard curve approach: Include a dilution series of recombinant YPR011C protein to create a standard curve on each blot.

  • Loading controls: Use mitochondrial proteins like porin/VDAC or TOM20 rather than cytosolic proteins like actin or GAPDH for normalization.

  • Sample preparation: Ensure complete solubilization of membrane-bound YPR011C using appropriate detergents.

  • Analysis: Use specialized software (ImageJ, Image Studio, etc.) for densitometry with background subtraction and normalization .

• Enzyme-Linked Immunosorbent Assay (ELISA):

  • Develop a sandwich ELISA using two antibodies recognizing different epitopes of YPR011C.

  • Implement a standard curve using purified recombinant YPR011C protein .

  • For cell lysates, ensure complete solubilization of membrane proteins using detergents compatible with the ELISA format.

  • Include spike-in recovery controls to assess matrix effects from yeast lysates.

• Flow Cytometry for Isolated Mitochondria:

  • Isolate intact mitochondria from yeast cells.

  • Permeabilize mitochondria and stain with YPR011C antibodies followed by fluorophore-conjugated secondary antibodies.

  • Use flow cytometry to quantify fluorescence intensity as a measure of YPR011C expression.

  • Include appropriate controls (YPR011CΔ mitochondria, isotype controls).

• Immunofluorescence Quantification:

  • Perform immunofluorescence staining of fixed yeast cells.

  • Capture images using confocal microscopy with identical acquisition settings across samples.

  • Quantify fluorescence intensity using software like ImageJ, CellProfiler, or specialized microscopy analysis software.

  • Co-stain with mitochondrial markers to define regions of interest for quantification.

• Mass Spectrometry-Based Approaches:

  • Use immunoprecipitation with YPR011C antibodies to enrich the target protein.

  • Perform targeted mass spectrometry (selected reaction monitoring or parallel reaction monitoring) using stable isotope-labeled peptide standards for absolute quantification.

  • This approach can also identify and quantify post-translational modifications.

• Multiplex Analysis:

  • For simultaneous quantification of YPR011C and related proteins, use multiplex western blotting with spectrally distinct fluorophores.

  • Alternatively, develop bead-based immunoassays for multiplex protein quantification from a single sample.

When implementing these methods, normalize data to account for variations in mitochondrial content between samples, particularly when comparing different growth conditions or mutant strains that may affect mitochondrial biogenesis.

How can I optimize antibody dilutions for different YPR011C detection techniques?

Optimizing antibody dilutions for YPR011C detection requires systematic testing across different techniques while considering the unique properties of mitochondrial membrane proteins. Here's a methodological approach for each technique:

• Western Blot Optimization:

  • Titration matrix approach: Prepare a grid testing primary antibody dilutions (1:250, 1:500, 1:1000, 1:2000, 1:5000) against secondary antibody dilutions (1:2000, 1:5000, 1:10000, 1:20000).

  • Positive controls: Include recombinant YPR011C protein at known concentrations .

  • Negative controls: Include samples from YPR011CΔ strains .

  • Protein loading: Test different amounts of mitochondrial protein (10μg, 20μg, 40μg) to find the optimal signal-to-noise ratio.

  • Evaluation criteria: Select the combination that gives specific signal with minimal background and is within the linear range of detection.

• Immunofluorescence Optimization:

  • Serial dilution test: Start with manufacturer's recommended range, typically testing 1:50, 1:100, 1:200, 1:500, and 1:1000 dilutions.

  • Incubation conditions: Test both overnight incubation at 4°C and 1-2 hour incubation at room temperature.

  • Blocking optimization: Test different blocking agents (BSA, normal serum, commercial blockers) and concentrations (3-5%).

  • Signal amplification: For weak signals, consider tyramide signal amplification systems.

  • Evaluation: Score samples based on signal-to-noise ratio, mitochondrial specificity (using co-localization with known markers), and absence of signal in YPR011CΔ controls.

• ELISA Optimization:

  • Antibody concentration matrix: Test coating antibody concentrations (1-10 μg/ml) against detection antibody dilutions (1:500-1:10000).

  • Standard curve: Include a standard curve of recombinant YPR011C to determine detection limits.

  • Blocking optimization: Test different blocking agents and determine optimal blocking time.

  • Sample dilution: Test multiple dilutions of your mitochondrial extract to ensure readings fall within the linear range of the assay.

  • Evaluation: Select conditions that provide the widest dynamic range with consistent replication and low background.

• Flow Cytometry Optimization:

  • Antibody titration: Test antibody dilutions ranging from 1:50 to 1:1000.

  • Signal-to-noise assessment: Calculate the ratio of median fluorescence intensity between positive and negative controls.

  • Compensation controls: Include single-color controls when performing multi-parameter analysis.

  • Live/dead discrimination: Include viability dyes when working with isolated mitochondria.

• Dot Blot for Initial Screening:

  • Before committing to full experiments, use dot blots with serial dilutions of both antibody and antigen to quickly determine approximate optimal concentrations.

• Documentation and Standardization:

  • Record all optimization parameters in a detailed protocol.

  • Once optimized, prepare antibody aliquots to ensure consistency across experiments.

  • Include internal controls in each experiment to monitor for drift in antibody performance over time.

Remember that optimal dilutions may vary between antibody lots and sample types, necessitating re-optimization when changing key experimental parameters.

How can YPR011C antibodies be used to investigate the relationship between mitochondrial transport and sulfur metabolism?

YPR011C antibodies can be powerful tools for investigating the intricate relationship between mitochondrial transport and sulfur metabolism through several advanced research approaches:

• Dynamic protein interaction studies under metabolic shifts:

  • Use YPR011C antibodies for co-immunoprecipitation studies under different sulfur availability conditions.

  • Compare protein interaction partners when cells are grown in media with or without methionine, which affects the sulfur assimilation pathway.

  • Identify how metabolic shifts alter the interactome of YPR011C, potentially revealing regulatory mechanisms linking transport to metabolism .

• Subcellular fractionation with metabolite analysis:

  • Fractionate yeast cells to isolate mitochondria, cytosol, and other compartments.

  • Use YPR011C antibodies to confirm proper fractionation and quantify YPR011C levels in each fraction.

  • Correlate YPR011C protein levels with metabolite concentrations (APS, PAPS, methionine, glutathione) in the same fractions using mass spectrometry.

  • This approach can reveal how YPR011C expression correlates with metabolite distribution across cellular compartments .

• Proximity labeling combined with metabolomics:

  • Generate a YPR011C fusion with a proximity labeling enzyme (BioID, APEX).

  • Use YPR011C antibodies to confirm expression and localization of the fusion protein.

  • Activate proximity labeling to biotinylate proteins and metabolites near YPR011C.

  • Analyze labeled proteins and metabolites to create a spatial map of the sulfur metabolism machinery in relation to YPR011C.

• In situ structural studies:

  • Apply YPR011C antibodies in electron microscopy studies to visualize the protein's distribution within mitochondrial membranes.

  • Use super-resolution microscopy with YPR011C antibodies to examine its spatial relationship with other components of sulfur metabolism pathways.

  • These approaches can reveal structural insights into how transport and metabolism are physically organized within cells.

• Stress response dynamics:

  • Monitor YPR011C expression, localization, and post-translational modifications during thermal stress using specific antibodies.

  • Correlate these changes with alterations in cellular levels of methionine and glutathione.

  • This approach can elucidate how YPR011C-mediated transport responds to and influences the cellular stress response .

• Genetic interaction mapping:

  • In strains with mutations in sulfur metabolism genes (MET3, MET14), use YPR011C antibodies to assess compensatory changes in protein expression.

  • Compare protein levels in single mutants (YPR011CΔ, MET3Δ-mtMet3p) versus double mutants (YPR011cΔMET3Δ-mtMet3p) to understand genetic interactions .

  • Correlate protein levels with phenotypic outcomes such as thermotolerance and metabolite production.

• Time-resolved studies during mitochondrial biogenesis:

  • Use YPR011C antibodies to track protein import and assembly during mitochondrial biogenesis.

  • Correlate the timing of YPR011C incorporation into mitochondria with the establishment of transport capacity for sulfur metabolism intermediates.

These advanced applications leverage YPR011C antibodies not just for detection, but as tools to unravel complex biological relationships between mitochondrial transport systems and cellular metabolism.

How can I integrate YPR011C antibody-based protein detection with functional transport assays?

Integrating YPR011C antibody-based protein detection with functional transport assays requires sophisticated methodological approaches that connect protein presence and abundance with transport activity. Here's a comprehensive strategy:

• Correlation of protein levels with transport kinetics:

  • Quantify YPR011C protein levels using antibody-based techniques (western blot, ELISA) in samples with varying transport activities.

  • Perform functional transport assays using reconstituted proteoliposomes containing YPR011C to measure substrate exchange rates (e.g., [35S]sulfate/sulfate exchange) .

  • Plot transport activity against protein abundance to establish quantitative relationships.

  • This approach can determine whether transport activity is limited by protein amount or regulated by post-translational modifications.

• Immunodepletion studies with activity rescue:

  • Use YPR011C antibodies to immunodeplete the protein from solubilized mitochondrial extracts.

  • Measure transport activity before and after immunodepletion.

  • Perform rescue experiments by adding back purified recombinant YPR011C protein.

  • This confirms the specific contribution of YPR011C to the measured transport activity.

• Real-time monitoring of transport with localization:

  • Develop fluorescent substrate analogs for APS/PAPS that can be tracked in living cells.

  • Perform time-lapse microscopy to monitor substrate transport while simultaneously tracking YPR011C location using fluorescent protein tags or specific antibodies in fixed time points.

  • Correlate substrate movement with YPR011C distribution patterns.

• Structure-function analysis with antibody epitope mapping:

  • Generate a panel of antibodies targeting different epitopes across YPR011C.

  • Test which antibodies inhibit transport function when added to reconstituted proteoliposomes.

  • Map the functional domains of YPR011C by correlating epitope locations with inhibitory effects.

  • This approach identifies critical regions for substrate binding and translocation.

• Modulation of transport by antibody-detected post-translational modifications:

  • Use modification-specific antibodies to detect and quantify post-translational modifications of YPR011C (phosphorylation, acetylation, etc.).

  • Correlate modification status with transport activity under different cellular conditions.

  • Implement site-directed mutagenesis to mimic or prevent specific modifications and measure resulting transport activity.

• Single-particle analyses:

  • Immobilize functional proteoliposomes containing YPR011C on biosensor surfaces.

  • Use antibody-based detection to confirm protein orientation and density.

  • Perform single-particle transport measurements using microfluidics and fluorescent substrates.

  • This approach reveals population heterogeneity in transport function that might be masked in bulk assays.

• Inhibitor studies with conformational-specific antibodies:

  • Develop antibodies that recognize specific conformational states of YPR011C during the transport cycle.

  • Use these antibodies to "lock" the protein in particular conformations.

  • Measure how this affects transport kinetics and substrate binding.

  • This approach can provide mechanistic insights into the transport cycle.

• In situ transport activity mapping:

  • Use fluorescent metabolic sensors to detect local concentrations of transported substrates in different cellular compartments.

  • Correlate these measurements with YPR011C abundance and localization detected by immunofluorescence.

  • This approach connects transport activity to physiological outcomes in intact cells.

By implementing these integrated approaches, researchers can establish causative relationships between YPR011C protein characteristics (abundance, localization, modifications) and its functional transport capacity, advancing our understanding of mitochondrial substrate transport mechanisms.

What are the most advanced techniques for studying YPR011C post-translational modifications using specific antibodies?

Studying post-translational modifications (PTMs) of YPR011C using antibody-based approaches requires sophisticated techniques that combine specificity with sensitivity. Here are advanced methodological approaches:

• Development of modification-specific antibodies:

  • Generate antibodies that specifically recognize phosphorylated, acetylated, ubiquitinated, or otherwise modified forms of YPR011C.

  • Validate specificity using synthetic modified peptides, in vitro modified recombinant proteins, and appropriate enzymatic treatments (phosphatases, deacetylases) to remove modifications.

  • Implement rigorous controls including competition with modified and unmodified peptides to ensure specificity.

• Two-dimensional gel electrophoresis with immunoblotting:

  • Separate YPR011C protein forms first by isoelectric point (using IEF buffers as in Table 2.21) and then by molecular weight (using SDS-PAGE) .

  • Transfer to membranes and probe with YPR011C antibodies to detect modification-induced shifts in migration patterns.

  • Use modification-specific antibodies in parallel blots to confirm the nature of modifications.

  • Follow detailed protocols for IEF conditions (Table 2.26) and IPG strip equilibration (Table 2.22) .

• Phos-tag™ SDS-PAGE for phosphorylation analysis:

  • Incorporate Phos-tag™ molecules into acrylamide gels to specifically retard the migration of phosphorylated proteins.

  • Perform western blotting with YPR011C antibodies to detect mobility shifts caused by phosphorylation.

  • Compare migration patterns before and after phosphatase treatment to confirm phosphorylation-dependent shifts.

• Immunoprecipitation coupled with mass spectrometry:

  • Use YPR011C antibodies to immunoprecipitate the protein from yeast lysates under various conditions (normal growth, thermal stress, sulfur limitation).

  • Analyze immunoprecipitated proteins by mass spectrometry to identify and quantify PTMs.

  • Implement SILAC or TMT labeling for quantitative comparison of modification states across conditions.

  • Validate key findings with modification-specific antibodies if available.

• Proximity-dependent labeling of PTM enzymes:

  • Fuse YPR011C with BioID or APEX2 enzymes for proximity labeling.

  • Use YPR011C antibodies to confirm expression and localization of the fusion protein.

  • Identify enzymes (kinases, phosphatases, acetyltransferases) that are proximal to YPR011C and may regulate its modifications.

• Single-molecule imaging of PTM dynamics:

  • Implement antibody-based FRET sensors that detect conformational changes associated with specific modifications.

  • Use modification-specific antibodies labeled with donor fluorophores and pan-YPR011C antibodies labeled with acceptor fluorophores.

  • Monitor FRET signals in real-time to track modification dynamics in response to cellular stimuli.

• Microfluidic antibody-based PTM profiling:

  • Develop microfluidic platforms with immobilized YPR011C-specific and modification-specific antibodies.

  • Profile multiple PTMs simultaneously from small sample volumes.

  • This approach enables temporal profiling of modification patterns across different conditions.

• Multiplexed imaging of modification patterns:

  • Use multiplexed immunofluorescence (e.g., Imaging Mass Cytometry or CODEX) with antibodies against YPR011C and various PTMs.

  • This approach can reveal spatial relationships between differently modified subpopulations of YPR011C within mitochondria.

• Functional correlation of PTMs:

  • Correlate identified PTMs with YPR011C transport activity in reconstituted systems .

  • Use site-directed mutagenesis to generate modification-mimicking or modification-preventing variants.

  • Assess how these modifications affect protein stability, localization, and function.

These advanced techniques can provide unprecedented insights into how post-translational modifications regulate YPR011C function in response to cellular conditions, particularly during thermal stress or changes in sulfur metabolism .

What are the most promising future directions for YPR011C antibody research?

The exploration of YPR011C using antibody-based approaches holds significant promise for advancing our understanding of mitochondrial transport processes and their integration with cellular metabolism. Several promising future directions emerge from current research:

• Systems-level analysis of transport-metabolism interfaces: Developing antibody-based proteomics approaches to investigate how YPR011C and its interactome change under different metabolic conditions could reveal regulatory networks connecting transport systems with downstream metabolic pathways. This would contribute to a more comprehensive understanding of mitochondrial metabolism integration with cellular physiology .

• Single-cell analysis of YPR011C expression heterogeneity: Adapting YPR011C antibodies for single-cell proteomics or high-throughput immunofluorescence could reveal cell-to-cell variability in protein expression and localization. This might uncover previously unrecognized subpopulations of cells with distinct metabolic profiles and stress responses, particularly important during thermal stress conditions .

• Therapeutic targeting of human orthologs: Identifying human orthologs of YPR011C and developing specific antibodies against them could lead to new therapeutic approaches for mitochondrial disorders involving sulfur metabolism. The characterized transport function and stress response role of YPR011C suggest potential disease relevance for its human counterparts .

• In situ structural biology: Combining YPR011C antibodies with emerging techniques like proximity labeling and cryo-electron tomography could reveal the structural organization of transport complexes within native mitochondrial membranes, providing unprecedented insights into how these proteins function in their natural environment.

• Integration with metabolic flux analysis: Developing methods to correlate YPR011C abundance and localization (detected via antibodies) with real-time metabolite flux measurements would create a dynamic picture of how transport capacity influences metabolic outputs. This could be particularly valuable for understanding cellular adaptations to stress conditions .

• Cross-species comparative analysis: Developing antibodies against YPR011C orthologs across different species could facilitate evolutionary studies of mitochondrial transport systems and their role in metabolic adaptation, potentially revealing conserved regulatory mechanisms.

• Novel antibody formats for functional modulation: Exploring the development of function-modulating antibodies or antibody fragments that can alter YPR011C transport activity could provide new tools for manipulating mitochondrial metabolism in experimental systems.

• Antibody-based diagnostics for mitochondrial function: Building on understanding of YPR011C's role in thermal stress response, developing antibody-based assays to monitor mitochondrial transport capacity could create new diagnostic tools for assessing mitochondrial health in various experimental and potentially clinical contexts .

These future directions leverage the specificity and versatility of antibody-based approaches to address fundamental questions about mitochondrial transport biology while potentially opening new avenues for diagnostic and therapeutic applications.

What important knowledge gaps remain in our understanding of YPR011C function and regulation?

Despite significant advances in characterizing YPR011C, several critical knowledge gaps remain that limit our comprehensive understanding of this mitochondrial carrier protein. These gaps represent important targets for future research:

• Regulatory mechanisms controlling expression and activity: While YPR011C has been linked to thermotolerance and sulfur metabolism, the precise mechanisms regulating its expression, trafficking, and activity remain poorly characterized . How various cellular signaling pathways modulate YPR011C function in response to different stress conditions is not fully understood.

• Complete post-translational modification profile: The post-translational modifications that regulate YPR011C activity, particularly during stress responses, have not been comprehensively mapped. Understanding how these modifications affect transport kinetics, substrate specificity, and protein-protein interactions would provide important insights into regulatory mechanisms .

• Structural determinants of substrate specificity: While functional studies have identified APS and PAPS as preferred substrates, the specific structural features and residues responsible for substrate recognition and transport have not been precisely defined . This limits our ability to predict how mutations might affect function or to design targeted interventions.

• Comprehensive interactome in different cellular states: The protein interaction network of YPR011C likely changes during different cellular conditions, but these dynamic interactions remain largely uncharacterized. Identifying condition-specific interaction partners would illuminate how YPR011C function is integrated with broader cellular processes .

• Bidirectional transport regulation: The mechanisms controlling the directionality of transport (import vs. export) across the mitochondrial membrane remain unclear. Understanding how the cell regulates the net flux of substrates through YPR011C is critical for understanding its physiological role .

• Relationship with other mitochondrial transporters: How YPR011C functionally interacts with other mitochondrial carriers to coordinate metabolite transport across the inner membrane is not well defined. This network-level understanding would provide insights into mitochondrial metabolism integration.

• Tissue and condition-specific roles in higher eukaryotes: While yeast studies have revealed important functions, the roles of YPR011C orthologs in multicellular organisms across different tissues and developmental stages remain to be fully characterized. This knowledge would illuminate how these transport functions have evolved and specialized.

• Impact on mitochondrial dynamics and quality control: The relationship between YPR011C function and broader aspects of mitochondrial biology—including fusion, fission, and mitophagy—has not been extensively investigated. Understanding these connections would place YPR011C in the broader context of mitochondrial homeostasis.

• Potential moonlighting functions: Many mitochondrial proteins perform additional functions beyond their primary role. Whether YPR011C has additional functions beyond metabolite transport, particularly under stress conditions, remains an open question .

Addressing these knowledge gaps will require integrated approaches combining structural biology, systems biology, and detailed mechanistic studies, with antibody-based techniques playing a crucial role in many of these investigations.

How does research on YPR011C contribute to our broader understanding of mitochondrial carrier proteins?

Research on YPR011C provides valuable insights that extend to our broader understanding of mitochondrial carrier proteins and cellular metabolism in several significant ways:

• Expanding the functional diversity of mitochondrial carriers: YPR011C's specificity for adenosine 5′-phosphosulfate (APS) and 3′-phospho-adenosine 5′-phosphosulfate (PAPS) demonstrates that mitochondrial carriers can transport specialized metabolites beyond the well-characterized energy intermediates like ATP/ADP . This expands our understanding of how mitochondria integrate with specialized metabolic pathways beyond energy metabolism.

• Linking transport functions to stress responses: YPR011C's role in thermotolerance establishes a direct connection between specific mitochondrial transport activities and cellular stress responses . This suggests that other mitochondrial carriers may similarly contribute to stress adaptation mechanisms, potentially through regulating the compartmentalization of critical metabolites.

• Elucidating the import and assembly of carrier proteins: Studies showing that YPR011C is inserted into the inner mitochondrial membrane by the TIM22 complex with the contribution of small Tim proteins provide mechanistic insights into how carrier proteins are properly targeted and assembled . This information is applicable to understanding the biogenesis of the entire mitochondrial carrier protein family.

• Demonstrating compartmentalization of metabolic pathways: YPR011C's role in shuttling sulfur metabolism intermediates between mitochondria and cytosol illustrates how metabolic pathways can be distributed across subcellular compartments, requiring coordinated transport systems . This paradigm is likely applicable to many other metabolic networks that span multiple cellular compartments.

• Revealing regulatory mechanisms in transport systems: The inhibition profiles of YPR011C by various compounds provide insights into structural and functional features that may be shared across the carrier family . The differential inhibition by bongkrekic acid (partial inhibition) versus carboxyatractyloside (minimal effect) suggests mechanistic similarities and differences with the well-studied ADP/ATP carrier.

• Connecting transport deficiencies to phenotypic outcomes: The observation that YPR011CΔ mutants have reduced levels of methionine and glutathione and decreased thermotolerance demonstrates how specific transport deficiencies can have cascading effects on cellular physiology . This establishes a framework for understanding the broader consequences of mitochondrial transport defects.

• Providing evolutionary insights: The finding that YPR011C clusters with CoA transporters from S. cerevisiae, plants, and humans in phylogenetic analyses suggests evolutionary relationships that can inform our understanding of how transport functions have evolved and diversified across species .

• Illustrating methodological approaches for carrier characterization: The comprehensive functional characterization of YPR011C—from recombinant expression and reconstitution to in vivo physiological studies—provides a methodological template applicable to studying other uncharacterized mitochondrial carriers .